Notice of Change to Application Due Date for RFA-RM-22-016 "Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)"
Notice Number:
NOT-RM-22-018

Key Dates

Release Date:

July 6, 2022

Related Announcements

RFA-RM-22-016 - Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

The purpose of this Notice is to inform applicants of changes to the Application Due Date and and Expiration Date for RFA-RM-22-016 "Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)". The following section has been modified to reflect changes to the due date for new applications:

Currently Dates:

Key Dates

Open Date (Earliest Submission Date)

June 17, 2022

Letter of Intent Due Date(s)

June 17, 2022

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

July 19, 2022

Not Applicable

Not Applicable

November 2022

January 2023

April 2023

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

July 20, 2022


Modified to Read (changes shown in bold italics)

Key Dates

Open Date (Earliest Submission Date)

June 17, 2022

Letter of Intent Due Date(s)

October 7, 2022

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

November 10, 2022

Not Applicable

Not Applicable

March 2023

May 2023

August 2023

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

November 11, 2022

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Philip J. ("Pj") Brooks, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-443-0513
Email: pj.brooks@mail.nih.gov